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Streptococcus dysgalactiae subsp. equisimilis (SDSE) has emerged as an important cause of severe 
skin and soft tissue infections, but little is known of the pathogenic mechanisms underlying tissue 






higher Streptokinase and Streptolysin O (SLO) activities, as compared to non-invasive strains. The 
opposite was true for Streptolysin S (SLS). Fractionation and proteomic analysis of the cytotoxic 
fractions implicated SLO as a factor likely contributing to the keratinocyte cytotoxicity and tissue 
pathology. Analyses of patient tissue biopsies revealed massive bacterial load, high expression of 
slo, as well as immune cell infiltration and pro-inflammatory markers. Our findings suggest the 
contribution of SLO to epithelial cytotoxicity and tissue pathology in SDSE tissue infections.
In all ages, simple skin and soft tissue infections are common. In contrast, severe soft tissue infections are 
far less frequent, but yet represent a great health and resource burden. Necrotizing soft tissue infections 
(NSTIs) are the most extreme end of skin and soft tissue infections and the vast majority of NSTI patients 
require intensive care and extensive surgical interventions to remove necrotic tissue. Despite many 
improvements in medical care, the mortality associated with NSTIs has not changed during the last dec-
ades and remains above 20%1,2. Although a number of bacteria can cause NSTI, including gram-negative 
bacilli, Staphylococcus aureus, and Clostridum spp, the main causative microbe is group A streptococcus 
(GAS). However, Streptococcus dysgalactiae subspecies equisimilis (SDSE) has emerged as an important 
cause of invasive infections, in particular those associated with skin and soft tissue including NSTIs3–7.
SDSE is a commensal constituent of the human microbiota and was long considered less patho-
genic than other streptococci8. However, several publications have reported invasive infections caused by 
beta-hemolytic SDSE, which almost exclusively belongs to group G or C streptococci (GGS, GCS)5,9–11. 
SDSE infections often present as superficial skin and soft tissue infections, including cellulitis and erysip-
elas. More rarely, life-threatening NSTIs and streptococcal toxic shock syndrome (STSS) may develop12–14. 
Primary focal infections are considered to be ports of entry leading to severe outcome15.
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Certain GAS emm-types, particularly emm1 and emm3, are over-represented in severe cases and have 
been linked to NSTI, STSS, and mortality16. In case of SDSE, there is no clear link between clinical sever-
ity and emm-types. Recent studies in the US and Norway suggested stG643 as a dominant emm-type17,18, 
whereas this type was completely absent in a Japanese study7. According to several studies of invasive 
beta-hemolytic streptococcal infections, SDSE infected patients tended to be older and had more often 
underlying conditions than GAS patients4,7,19–21.
In NSTIs the rapid tissue destruction is proposed to involve toxin induced neutrophil aggregate-mediated 
vascular occlusion, followed by ischemia which expands until the tissue is destroyed22. In GAS NSTI sev-
eral factors have been proposed to contribute to tissue pathology including among others superantigens, 
M1-protein, the cysteine protease SpeB, and a pathologic host inflammatory response23. However, data 
on the contribution of virulence factors to severe outcome of SDSE infections are scarce. SDSE are phy-
logenetically related to GAS and they share several virulence factors, including antiphagocytic M-Protein, 
Streptolysin S (SLS), Streptolysin O (SLO) and Streptokinase (Ska)6,18,24–26. Although SDSE strains may 
harbor superantigen genes, i.e. speGdys, no superantigenic activity has been detected27.
We sought to deepen our insight into the pathogenesis of invasive SDSE infections with a particu-
lar focus on tissue pathology. To this end, a clinical group G SDSE strain collection from invasive and 
non-invasive cases was analyzed for virulence factor expression and their effect on human keratinocytes, 
immune cells, and in organotypic skin tissue. The results implicated SLO as a key factor mediating cyto-
toxicity and tissue pathology in SDSE skin and soft tissue infections.
Results
Bacterial dissemination and tissue pathology in organotypic skin models. To compare the 
ability of strains to colonize and invade complex tissue, organotypic skin tissue with a stratified epi-
thelium and a fibroblast dermal layer was created and infected with selected SDSE strains represent-
ing diverse types and different severity of infections. The strains were isolated from tissue or skin and 
included three invasive NSTI strains (4F1, 5005, and 6007) and one non-invasive strain (B35) derived 
from an uncomplicated wound infection. All four strains were able to colonize the tissue and bacterial 
replication was evident in all infected tissue (Fig. 1A,B). After eight hours of infection, the bacteria were 
found mainly associated with the apical side of the epidermis, while after 24 hours the invasive strains 
were frequently found in deeper epidermal layers whereas the non-invasive B35 strain remained associ-
ated with stratum corneum and did not disseminate to deeper layers (Fig. 1A).
Pathologic changes were assessed by microscopic analyses of hematoxylin/eosin stained tissue sec-
tions. This revealed that all three invasive strains caused severe tissue damage characterized by substantial 
epithelial disruption and detachment, which significantly increased over time (Fig.  1C,D). In contrast, 
B35 induced mild to moderate epithelial disruption (Fig. 1C,D).
Next, the bacterial impact on epidermal structural proteins was examined by immuno-staining and 
confocal microscopy analysis. As illustrated in Fig. 2A–E, significantly increased expression of the junc-
tion proteins claudin-1 and E-cadherin as well as the keratins K10 and K16 was evident at 8 hours 
post-infection. As the infection progressed, the expression levels of most proteins, except K10, declined 
to that of the uninfected control or even below, likely due to the loss of tissue integrity (Fig. 2A,B,E).
Since NSTIs are characterized by hyper-inflammation and necrosis, we analyzed the supernatants of 
infected skin tissue models for CXCL8 and HMGB-1, the latter being a marker for both necrosis and 
inflammation28. Both CXCL8 and HMGB1 were significantly increased already after eight hours of infec-
tions with all four strains (Fig. 2F–G). While CXCL8 levels were increasing over time, the maximum of 
HMGB1 was reached already at 8 hours post-infection, indicating that the cell and tissue injury occurs 
at the early stage of infection.
By virtue of their cytotoxic activity, it seemed likely that SLO and/or SLS could be involved in the 
noted tissue injury. To this end, gene expression analysis of infected skin tissue was performed (Fig. H–I). 
Expression data of stationary phase cultures of the bacterial isolates was set as reference (t0). The results 
show that slo was strongly induced in the tissue milieu, and among the invasive strains, slo showed the 
strongest induction within 8 hours and then returned to the same level as the reference (Fig.  2H). In 
contrast, no changes in sagA expression, gene encoding for SLS, were found in the majority of infections 
(Fig.  2I). Only in the 4F1 strain, sagA expression showed a peak at 8 hours post-infection and then 
declined to the reference level.
Cytotoxic  effects  towards  keratinocytes.  Taken together the results from infected skin models 
suggested that invasive SDSE strains were more cytotoxic resulting in greater tissue pathology. To further 
explore this finding, we analyzed the larger SDSE strain collection (Table S1) for cytotoxicity towards the 
epidermal keratinocyte cell line used to generate the skin models, i.e. N/TERT-1. First, live infections 
with selected strains were performed and infectivity as well as cytotoxicity was assessed (Fig. 3A,B). The 
results revealed that invasive SDSE strains had significantly higher infection rates and also resulted in 
higher cytotoxicity, as compared to non-invasive strains. Second, keratinocytes were stimulated with bac-
terial supernatants prepared from the entire strain collection (Table S1). Again supernatants from invasive 
strains elicited significantly higher cytotoxic effects as compared to non-invasive strains (Fig. 3C). Similar 
differences were seen using another keratinocyte cell line, HaCaT (Fig.  3D). In contrast, neither der-
mal fibroblasts or PBMC, nor primary neutrophils were affected by the bacterial supernatants (Fig. S1). 
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Thus the data demonstrate that keratinocytes are particularly susceptible to cytotoxicity elicited by SDSE 
exotoxins.
SLO mediated cytotoxicity towards keratinocytes. To explore whether streptolysins might be 
responsible for the noted cytotoxic effects towards keratinocytes, SLO, SLS as well as non SLO/SLS factors 
were assessed by a hemolytic assay in culture supernatants of all 69 clinical isolates. Significantly higher 
SLO activity was identified in invasive, as compared to non-invasive strains, whereas the reverse was true 
for SLS activity (Fig. 4A). Also, a hemolytic activity due to non SLO/SLS factors was measurable in all 
strains, but there was no difference between invasive and non-invasive (Fig. 4A). A positive correlation 
between SLO activity and keratinocyte cytotoxicity was found (Fig. 4B), whereas no such correlation was 
found with SLS or non SLS/SLO activity (Fig. S2).
Taken together, the data suggest that SLO might be responsible for the cytotoxicity towards keratino-
cytes. To further explore this, we performed fractionation, protein inactivation and proteomic analysis 
of cytotoxic fractions. For this purpose, we used two strains: one invasive (4F1) highly cytotoxic and one 
non-invasive (B35) eliciting lower cytotoxicity. Heat-inactivation or pepsin-treatment of the supernatants 
Figure 1. SDSE infections in skin tissue model. (A) Representative micrographs of Gram-stained infected 
tissue with indicated SDSE strains and total CFU counts (B) of bacteria recovered from skin tissue models. 
The data represent the mean values ± SD (n = 3). (C) Histological analysis of the skin model tissue after 
infection. Representative images with indicated time points post infection with indicated strains are shown. 
(D) Blinded scoring of tissue pathology of the skin model after infection. Horizontal lines denote median 
values. The statistical significance was determined using Kruskal-Wallis with Dunn´s multiple comparison 
test. (*p < 0.05; **p < 0.01; ***p < 0.001).
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almost completely abolished the cytotoxic activity; thus, indicating the protein nature of the cytotoxic 
factor (Fig. 4C). Next, the supernatants were separated in two fractions with a 30 kDa cut off using fil-
ter ultra-centrifugation. The cytotoxic activity was predominantly found in the > 30 kDa fraction from 
invasive 4F1 strain (Fig. 4C). B35 strain with less active SLO showed minor cytotoxic effects. Proteomic 
analysis of > 30 kDa fractions from both 4F1 and B35 identified several virulence factors, including SLO, 
streptokinase, phosphoglycerate kinase (PGK), enolase (Eno), glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH), and M protein. Notably, SLO was the only factor identified that had previously been 
ascribed cytolytic activity (Table 1 and Table S2). Since Streptokinase (Ska), a fibrinolytic factor secreted 
by streptococci, was also identified in > 30 kDa fraction, we tested its activity in the entire cohort. This 
revealed significantly higher Ska activity in invasive strains compared to non-invasive (Fig. 4D).
Streptolysins, immune cells and pro-inflammatory/necrotic markers in patient samples.  Next, 
we analyzed tissue biopsies from the NSTI patients 5005 and 6007 to test the clinical relevance of our 
in vitro findings. Gram-staining detected massive bacterial load in the biopsies with Gram-positive 
chains, aggregations as well as single cocci found in all analyzed tissues (Fig. 5A). The gene expression 
of slo and sagA (SLS) in the day 0 tissue biopsies were determined, and in both patients the expression 
exceeded that of stationary phase in vitro bacterial cultures (Fig. 5B,C). In accordance with the results 
of infected skin tissue model, both HMGB1 and CXCL8 were readily detectable in the tissue biopsies 
(Fig. 5D,E). Also infiltrating phagocytic cells like macrophages (CD68) and neutrophils (NE), as well as 
the severity markers resistin and heparin binding protein (HBP) were present in the tissue (Fig. 5D). In 
situ image analysis of the stained tissue confirmed high levels of the markers in the tissue collected at 
both days 0 and 1 (Fig. 5E).
Also plasma samples from patients 5005 and 6007 were analyzed for a panel of inflammatory markers, 
including CXCL8, IL-6, MCP-1, and IL-10 (Fig. 6A–D). The results revealed high levels of CXCL8, IL-6 
and MCP-1 in day 0 samples. Also IL-10 was detected, although at lower levels. Similarly, stimulation of 
Figure 2. The impact of SDSE infection on epidermal tissue integrity and inflammation.  
(A) Representative immuno-staining of Claudin-1 and MFI (B–E) analysis of protein expression patterns 
of indicated proteins during the infection compared to the uninfected control (dashed line). Detection of 
CXCL8 (F) and HMGB1 (G) levels in model culture supernatants. (H–I) Relative mRNA expression of genes 
encoding for streptococcal virulence factors before (stationary phase cultures, t0) and during the infection 
in model tissue. Relative expression of slo and sagA before and during the infection are shown. The data 
represent the mean values ± SD (n ≥ 3). The statistical significance was determined using Kruskal-Wallis 
with Dunn´s multiple comparison test. (*p < 0.05; **p < 0.01; ***p < 0.001).
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PBMCs with bacterial supernatants from strains 5005, 6007, 4F1, and B35 showed that all strains elicited 
high levels of CXCL8, IL-6, MCP-1, and somewhat lower IL-10 (Fig. 6A–D).
As superantigens are major mediators of systemic toxicity in GAS infections29,30 and the superantigen 
gene speGdys was identified in the majority of the SDSE strains (Table S1), we tested the superantigenic 
activity of the SDSE strains. However, no proliferation of PBMC was triggered by any of the SDSE strains. 
Only the positive controls, PHA and GAS supernatant induced proliferation (Fig. S3).
Discussion
Since the last decade an increasing burden of invasive infections, including also cases of NSTI and STSS, 
due to SDSE has been reported, and some countries even report a disease burden comparable to GAS12–14,31. 
Although SDSE share some of the virulence factors produced by GAS, such as superantigens (i.e. speGdys), 
M protein, SLO, SLS, and Ska6,18,24–26, little is known of their contribution to disease pathogenesis. Here 
we demonstrate that clinical group G SDSE strains efficiently infect human skin tissue and cause tissue 
pathology. Notably, severity of infection was related to keratinocyte cytotoxicity, epithelial damage in 
the skin tissue model, as well as SLO activity with increased activities noted in invasive as compared to 
non-invasive strains. Also, slo gene expression was found to be highly expressed in NSTI patient tissue 
biopsies. Additional analyses including fractionation and proteomics further implicated SLO as the cyto-
toxic factor responsible for the SDSE-mediated tissue pathology.
In in vivo murine experimental models, SLO has been reported as a factor contributing to GAS tissue 
infections32. In contrast, Humar and colleagues5 suggested that SLS contributed to NSTI via direct cyto-
toxicity to cells of the tissue and feeding vessels, leading to cell death and provoking neutrophil influx. 
This contradicts to our data in which no association with SLS activity and cytotoxicity to keratinocytes 
or skin tissue could be noted. One plausible explanation is that our study focuses on human cells, which 
may have different susceptibility to the streptolysins, as compared to murine cells used in5. Instead, our 
data supports a role for SLO in SDSE skin and soft tissue infections, in concordance with what was 
reported in GAS infections.
We are in this study focusing on tissue infection and for this purpose we have created and used 
organotypic skin tissue, which resembles real skin inasmuch as it provides a protective physiological bar-
rier and consists of stratified epithelium and dermal layer containing fibroblasts. The SDSE strains, both 
invasive and non-invasive, could efficiently infect the skin tissue and showed similar massive bacterial 
load as evident in patient tissue biopsies. However, especially the invasive strains showed dissemination 
Figure 3. SDSE induced cytotoxicity towards human keratinocytes. (A) Total bacterial counts (selected 
cohort) recovered from N/TERT-1 cells 2 hours post infection and cytotoxicity towards these cells (B).  
(C) Cytotoxicity induced by bacterial supernatants from entire cohort on eukaryotic N/TERT-1 cells.  
(D) Cytotoxicity induced by bacterial supernatants from selected cohort on eukaryotic HaCaT cells. Each 
dot represents the mean vallue of three independent experiments with one strain. The horizontal lines 
within each group represent the mean value. The statistical significance between the two groups was 
determined using two-tailed Mann-Whitney U-test.
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throughout the entire epithelium. As already discussed, these strains have higher SLO activity likely con-
tributing to the greater tissue disruption, which might promote dissemination. In addition, the invasive 
strains had significantly higher Ska activity as compared to non-invasive strains. As Ska is known to 
promote invasion through plasmin activation and subsequent proteolysis, it is tempting to assume that 
Figure 4. SLO-mediated cytotoxicity towards human keratinocytes. (A) Streptolysin activities in 
bacterial supernatants derived from stationary growth phase. Each dot represents the mean value of three 
independent experiments with one strain. The horizontal lines within each group represent the mean 
value. The statistical significance between the two groups was determined using two-tailed Mann-Whitney 
U-test. (B) Correlation analysis of SLO hemolytic activity and keratinocyte cytotoxic activity in bacterial 
supernatants. Correlation was determined using Pearson test. (C) Cytotoxicity induced by different fractions 
of bacterial supernatants from 4F1 and B35 strains (HI, heat inactivation; Pe, pepsin treatment). The data 
represent the mean values ± SD (n ≥ 3). The statistical significance between the two groups was determined 
using two-tailed Mann-Whitney U-test. (D) Streptokinase activities in bacterial supernatants derived from 
stationary growth phase. Each dot represents the mean value of three independent experiments with one 
strain. The horizontal lines within each group represent the mean value. The statistical significance between 
the two groups was determined using two-tailed Mann-Whitney U-test.
Category 4F1 >30 kDa B35 >30 kDa
Secreted









Table 1.  Virulence factors detected* in >30 kDa fractions of 4F1 and B35 strains. *Based on mass 
spectrometry analyses (GAPDH, glyceraldehyde-3-phosphate dehydrogenase; PGK, phosphoglycerate kinase; 
PAM, plasminogen binding group A streptococcal M-protein).
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also Ska could contribute to the noted increased bacterial dissemination. However, this warrants further 
investigations.
The SDSE infection, in both infected skin tissue and patient biopsies, resulted in high levels of the 
inflammatory markers CXCL8 and HMGB1, the latter of which is also associated with necrosis. This is 
in line with the recent report by Johansson et al.28, where HMGB1 was suggested to be a marker for 
severity of GAS NSTI. Also analyses in patient plasma identified high levels of pro-inflammatory factors 
and PBMCs responded strongly to SDSE bacterial supernatants with high cytokine production. The fac-
tors eliciting inflammatory responses are as of yet unknown, but there is no evidence, in this study nor 
in others, to support superantigenic activity.
Bruun and colleagues4 reported differences in clinical presentation of severe SDSE and GAS skin and 
soft tissues infections with the former being associated with anatomically more superficial presentation. 
This is in line with our data revealing SLO-mediated cytotoxicity of keratinocytes, rapid tissue injury 
in the epithelium of infected skin tissue, and a loss of tissue integrity with reduced claudin-1 and K16 
expression.
Figure 5. Infammation in patient biopsies as a result of high infiltration by bacteria and toxin 
production. (A) High bacterial load in patient biopsies visualized via Gram-staining. Relative mRNA 
expression of slo (B) and sagA (C) in patient biopsies. (D) Immunohistochemical detection of pro-
inflammatory markers HMGB1 and CXCL,8 infiltrating immune cells (macrophages [CD68] and neutrophils 
[NE]), and activation markers Resistin and HBP in patient biopsies. (E) Image analysis values for all markers 
in patient biopsies at different days post admission. The sections were analyzed by acquired computerized 
image analysis (ACIA). Mean values ± SD from two biopsies of each patient are shown (dpa, days post 
admission).
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To our knowledge, this is the first report that implicates SLO as a cytotoxic factor likely contrib-
uting to SDSE mediated severe skin and soft tissue infections. Further studies are warranted to test 
SLO-targeted interventions.
Methods
Patient samples and ethics statement. Snap-frozen tissue biopsies and plasma samples were 
collected from two group G SDSE NSTI patients (5005 and 6007) enrolled in the EU-funded project 
INFECT (www.fp7infect.eu) in Gothenburg (Sweden) and Bergen (Norway). Written informed consent 
was obtained from both patients. The studies were approved by the regional Ethical Review Boards in 
Gothenburg (Regionala etikprövningsnämnden, Göteborg) and in Bergen (Regionale komiteer for medi-
sinsk og helsefaglig forskningsetikk Vest).
Blood samples from healthy volunteers or buffy coats of blood provided by the blood bank at the 
Karolinska University Hospital were used. The buffy coats were provided anonymously; hence informed 
consent was not necessary. In case of healthy volunteers, donors were individuals well acquainted with 
the research conducted; thus, verbal informed consent was deemed sufficient. The ethical research com-
mittee at Huddinge University Hospital (Forskningskommitté Syd) approved the study including the 
above specified consent procedure.
All experiments were carried out in full accordance with the approved ethics applications specified 
above.
SDSE strains, human cells, and culture conditions. A collection of non-invasive (n = 19) and 
invasive (n = 50) group G SDSE isolates collected from patients identified at Haukeland University 
Hospital, Bergen, during the period from 2003 to 2013 was used4,18,24. All patients, except two, had 
tissue involvement of varying severity ranging from wound infection to NSTI. Clinical presentation, 
emm type and presence of speGdys are presented in Table S1. SDSE strains 5005 and 6007 were isolated 
from NSTI patients enrolled in the INFECT study during 2013. All SDSE strains were cultured in Todd 
Hewitt Broth (Invitrogen) supplemented with 1.5% (w/v) yeast extract (THY, Invitrogen) under 37 °C 
and 5% CO2 atmosphere. Cell-free supernatants were prepared from bacterial cultures by centrifugation 
at 4,000 × g, 10 minutes.
The human keratinocyte cell lines N/TERT-1 and HaCaT were cultured in EpiLife medium (Invitrogen) 
under 37 °C and 5% CO2 atmosphere.
Human neutrophils and PBMCs were isolated from peripheral blood collected from healthy donors 
by Polymorphprep or Ficoll-Hypaque gradient centrifugation (Axis-Shields), respectively. Both cell types 
were cultured in RPMI 1640 media (HyClone) supplemented with 5% (v/v) FCS.
Strain typing. Extraction of chromosomal DNA, emm-typing, and detection of speGdys were per-
formed as previously described4,18.
Figure 6. Cytokine release by human immune cells in response to SDSE supernatant stimulations. (A) 
IL-6, CXCL8 (B), IL-10 (C), and MCP-1 (D) release by PBMCs from two healthy donors after stimulation 
with supernatants from indicated strains (left panel) and in patient plasma samples (right panel). #, under 
detection limit. Mean values ± SD from two technical replica of each patient are shown (right panel).
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Streptolysin and streptokinase activity in bacterial supernatants. SLO, SLS and non SLO/SLS 
hemolytic activity was measured by use of the conventional erythrocyte lysis activity assay as previously 
published33 and the activities related to a water lysis control. THY was used as a negative control.
Ska activity was assessed by the chromogenic assay as previously published34. The activities were 
related to the activity of the plasmin control. THY was used as negative control.
Adherence, bacterial supernatant stimulations, and cytotoxicity LDH release assays. Bacterial 
adherence to epithelial cells was quantified using the antibiotic protection assay35. Cells were infected 
with SDSE strains at a multiplicity of infection of 1:10. Total bacterial counts after 2 hours of infection 
were determined by plating serial dilutions on blood agar plates. The results are shown as % of initial 
inoculum.
Cells were stimulated with bacterial supernatants (1:50 diluted). Keratinocytes (1.5 × 105) and PBMCs 
(8 × 105) were stimulated for 24 hours and neutrophils (8 × 105) for 2 h after which supernatants were 
collected. THY and TritonX-lysed cells were used as negative and positive controls, resp.
Cytotoxicity was determined by measurement of the LDH activity via CytoTox 96 Non-Radio Kit 
(Promega) according to manufacturer’s guidelines.
Cell proliferation assay. PBMCs (2.5 × 105 cells/well) were seeded in 96-well plates and stimulated 
for 72 h with varying dilutions of bacterial supernatants (1:10–1:1000). The cells were pulsed with 1 μ Ci 
of 3H-thymidine (GE Healthcare) for additional 6 h of incubation and the uptake of the 3H-thymidine 
was measured.
3D organotypic skin model.  The organotypic tissue was generated following the protocol of estab-
lished lung tissue model with minor modifications36. Briefly, dermal equivalents were generated by 
adding 1 ml cell-free collagen (1 mg/ml; Advanced Biomatrix) into a six well-filter insert (Corning Life 
Sciences). After polymerization, 3 ml of NHDF populated (0.4 × 105) collagen (2 mg/ml) was pipetted 
onto the polymerized collagen layer. After polymerization, dermal equivalents were submerged in DMEM 
medium for one week. After 7 days, 1 × 106 N/TERT-1 cells were seeded onto the dermal equivalent and 
incubated for 2 h at 37 °C under a 5% CO2 atmosphere after which 2 ml of EpiLife (Life Technologies) 
was added to each insert. Submerged cultures were incubated for additional 3 days. Then skin models 
were air exposed by removing the medium from the inserts and adding 10 ml 1.46 mM CaCl2-EpiLife 
to the outer chamber. Air-exposed skin models were incubated for up-to 7 d at 37 °C under a 5% CO2 
atmosphere, and the culture media was replaced every second day in the outer chamber. The models 
were infected with an optimal infectious dose of 1 × 106 bacteria for 8 and 24 h. Total bacterial counts 
(extra- and intracellular bacteria) from model tissue, which was digested with Collagenase I (Roche) and 
sonicated, were determined by plating serial dilution on blood agar plates.
RNA Preparation and Quantitative Reverse Transcription PCR Analysis (qRT-PCR). Bacterial 
RNA was isolated using FastRNA Blue (MP Biomedicals) according to manufacturer´s guidelines. cDNA 
synthesis was performed using the Superscript first-strand synthesis system for RT-PCR (Invitrogen). 
The real-time PCR amplification was performed with SYBR GreenER Kit (Invitrogen) using an ABI 
Prism 7500 sequence detection system (Applied Biosystems). The level of gyrA transcription was used 
for normalization of bacterial genes. The primers used in this study are published by Watanabe et al.33.
Protein extraction and digestion. Concentrated > 30 kDa fractions of bacterial supernatants were 
re-suspended in 0.1% ProteaseMax (Promega), 50 mM ammonium bicarbonate and 10% acetonitrile. 
Protein concentrations were determined using the BCA kit (Pierce). 5 μ g of each sample were incubated 
for 30 min at 50 °C followed by 10 min bath sonication at room temperature. Samples were centrifuged 
and the supernatant was directly subjected to a tryptic digestion protocol carried out by a liquid handling 
robot (MultiProbe II, Perkin Elmer).
Liquid chromatography tandem mass spectrometry. Tryptic peptides were cleaned with C18 
StageTips (Thermo Scientific) and the resulting peptide mixture was injected into an Ultimate sys-
tem (Thermo Scientific) in-line coupled to a Q Exactive mass spectrometer (Thermo Scientific). The 
chromatographic separation of the peptides was achieved using an in-house packed column (C18-AQ 
ReproSil-Pur® , Dr. Maisch GmbH). The MS acquisition method was comprised of one survey full scan 
ranging from m/z 300 to m/z 1650 acquired with a resolution of R = 70’000 at m/z 400, followed by 
data-dependent HCD scans from maximum ten most intense precursor ions.
Protein  identification  and  quantitation.  Tandem mass spectra were extracted using Raw2MGF 
(in-house software), and the resulting mascot generic files were searched against the firmicutes concat-
enated SwissProt protein database using the Mascot Deamon 2.4.1 search engine (Matrix Science Ltd.). 
Parameters were chosen as follows: up to two missed cleavage sites for trypsin, peptide mass tolerance 
10 ppm, 0.05 Da for the HCD fragment ions. Carbamidomethylation of cysteine was specified as a 
fixed modification, whereas oxidation of methionine and deamidation of asparagine and glutamine were 
defined as variable modifications.
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Histological analysis and immunostaining of tissue biopsies. For cryosectioning, skin tissue 
models were treated with 2.0 M sucrose for 1 hour before embedding in optimum cutting temperature 
compound (Sakura Finetek) followed by freezing in liquid nitrogen and stored at − 80 °C. 8 μ m cryosec-
tions were obtained using a MICROM cryostat HM 560 MV (Carl Zeiss) and fixed in 2% freshly prepared 
formaldehyde in PBS for 15 minutes at room temperature or in ice-cold acetone for 2 minutes at − 20 °C.
For histological analysis, the sections were stained for 15 seconds in Mayer’s haematoxylin and coun-
terstained for 2 minutes in eosin. Histological severity scoring was performed in a double blinded man-
ner using the following criteria, 0 unaffected tissue, 0.5–1 mild injury with minor epithelial loosening, 
1.5–2 moderate injury with some epithelial disruption, 2.5–3 severe injury with continuous epithelial 
disruption and some detachment, 4 = extensive injury, massive epithelial disruption and detachment. 
SDSE were identified via conventional Gram staining.
For immune analysis, skin models and patient biopsies were cryosectioned (8 μ m), fixed in 2% 
(v/v) formaldehyde and immunostained as previously described28. The following antibodies were used 
for immuno-histochemistry: anti-human HMGB1 (Abcam), anti-human IL8/NAP-1 (Invitrogen), 
anti-human resistin (R&D systems), anti-human CD68/EBM11 (DAKO), anti-human NE/NP57 (DAKO), 
and anti-human HBP (DAKO). Biotinylated secondary antibodies included goat-anti-mouse IgG and 
goat-anti-rabbit IgG (both from Vector Laboratories). The immunohistochemically stained sections were 
analyzed by acquired computerized image analysis (ACIA)28. In brief, the cell area was defined by the 
hematoxylin counterstaining and the results are presented as percent positively stained area × mean inten-
sity of positive staining. The following antibodies were used for immuno-fluorescence: anti-human clau-
din 1, anti-human cytokeratin 10, and anti-human cytokeratin 16 (all Abcam), anti-human E-cadherin 
(Invitrogen), anti-human fibronectin (Sigma). Specific staining was detected by Alexa 488-conjugated 
goat anti-mouse IgG and Alexa 488-conjugated goat anti-rabbit IgG (both from Molecular Probes). The 
stainings were visualized using a Nikon A1 confocal microscope (Nikon Instruments). The mean fluores-
cence intensity (MFI) in tissue sections was determined using NIS element AR image analysis software 
(Nikon).
Bio-Plex Pro multiplex immunoassay. Levels of IL-6, CXCL8, IL-10, TNFα , and MCP-1 in patient 
plasma or PBMC supernatants were determined using a Bio-Plex Pro Human Cytokine Assay Kit 
(Bio-Rad) and the MagPix instrument (Luminex) according to manufacturers’ guidelines.
CXCL8  and  HMGB1  Enzyme-linked  Immunosorbent Assay  (ELISA).  The culture media from 
unstimulated and infected models were collected and stored at − 20 °C until used. HMGB1 was quanti-
fied using a HMGB1 ELISA Kit (IBL International), and CXCL8 was determined using Il-8 Quantikine 
ELISA (R&D Systems) according to manufacturer´s guidelines.
Statistical analysis. The significance of differences in cytotoxicity, adherence, and toxin activity 
assays was determined using the non-parametric Mann-Whitney U-test, two-tailed. The significance 
of differences between skin model samples in protein expression and CXCL8 and HMGB1 release was 
determined using non-parametric ANOVA, i.e. Kruskal-Wallis with Dunn´s multiple comparison test. 
Correlation analyses of SLO, SLS, and non-SLO/SLS hemolytic activities and keratinocyte cytotoxicity 
were determined using Pearson test. All statistical analyses were performed using Prism version 6 soft-
ware (GraphPad). P < 0.05 was defined as statistically significant.
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